Stroke
The study might provide impetus for a randomized clinical trial in the United States, its investigators hope.
Despite a having a higher risk of poor outcomes and death compared with younger patients, the very elderly should not be barred from the therapy, the study authors say.
…
Despite the encouraging trends, only a minority of patients receive this type of care, the authors note.…
The most informative prognostic marker was a greater than 30% postprocedural improvement in NIHSS score.…
Increased use of glycoprotein IIb/IIIa inhibitors, angioplasty, or stenting may be required to achieve good outcomes in this population.…
Page 4 of 43